Kingsview Wealth Management LLC Acquires 299 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Kingsview Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 8.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,962 shares of the exchange traded fund’s stock after acquiring an additional 299 shares during the quarter. Kingsview Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $391,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in XBI. B. Riley Wealth Advisors Inc. boosted its stake in SPDR S&P Biotech ETF by 15.2% in the 1st quarter. B. Riley Wealth Advisors Inc. now owns 7,071 shares of the exchange traded fund’s stock valued at $671,000 after purchasing an additional 933 shares during the period. Comerica Bank boosted its stake in SPDR S&P Biotech ETF by 33.6% in the 1st quarter. Comerica Bank now owns 13,315 shares of the exchange traded fund’s stock valued at $1,263,000 after purchasing an additional 3,346 shares during the period. Cetera Investment Advisers boosted its stake in SPDR S&P Biotech ETF by 321.8% in the 1st quarter. Cetera Investment Advisers now owns 165,220 shares of the exchange traded fund’s stock valued at $15,678,000 after purchasing an additional 126,053 shares during the period. Cetera Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 70.4% in the 1st quarter. Cetera Advisors LLC now owns 97,284 shares of the exchange traded fund’s stock valued at $9,231,000 after purchasing an additional 40,184 shares during the period. Finally, Transcend Capital Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 7.5% in the 2nd quarter. Transcend Capital Advisors LLC now owns 54,109 shares of the exchange traded fund’s stock valued at $5,016,000 after purchasing an additional 3,774 shares during the period.

SPDR S&P Biotech ETF Price Performance

XBI opened at $100.00 on Friday. The company has a market capitalization of $7.62 billion, a PE ratio of 11.47 and a beta of 1.11. The business has a fifty day simple moving average of $98.31 and a 200 day simple moving average of $96.48. SPDR S&P Biotech ETF has a 1 year low of $72.10 and a 1 year high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.